Stockchase Opinions

Gordon Reid Amedisys Inc AMED-Q PAST TOP PICK Feb 02, 2011

(A Top Pick Feb 17/10. Down 40.3%.) Likes the home health care industry. Difficulty is the unknown regarding government reimbursement act, which is still up in the air. Very volatile.
$35.150

Stock price when the opinion was issued

medical services
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

BUY
Healthcare company involved in home healthcare. Has done very well and will continue to do so. Was held back because of fears of the US government changes in healthcare. Extremely well managed and trading at only 8X earnings.
TOP PICK
Home health care company for acute patients. Contributor to health care reform. Least expensive option for health care. Stock suffered from the overhang of health care reform. Recently doubled his position as a result of management changes and skittish market.
HOLD
Been a tough industry and tough company to own. Has been in the crosshairs of some of the regulators in Washington but the business is sound. It's home healthcare. People would rather be treated at home than in hospital and it's cheaper. Will probably earn over $4 a share this year, which is pretty attractive.